发布求助
文献互助 智能选刊 最新文献

Journal of cancer science and clinical therapeutics最新文献

筛选
英文 中文
A Web Application for Predicting Drug Combination Efficacy Using Monotherapy Data and IDACombo. 利用单一疗法数据和 IDACombo 预测联合用药疗效的网络应用程序。
Journal of cancer science and clinical therapeutics Pub Date : 2024-01-01 Epub Date: 2023-12-08 DOI: 10.26502/jcsct.5079218
Yunong Xia, Alexander L Ling, Weijie Zhang, Adam Lee, Mei-Chi Su, Robert F Gruener, Sampreeti Jena, Yingbo Huang, Siddhika Pareek, Yuting Shan, R Stephanie Huang
{"title":"A Web Application for Predicting Drug Combination Efficacy Using Monotherapy Data and IDACombo.","authors":"Yunong Xia, Alexander L Ling, Weijie Zhang, Adam Lee, Mei-Chi Su, Robert F Gruener, Sampreeti Jena, Yingbo Huang, Siddhika Pareek, Yuting Shan, R Stephanie Huang","doi":"10.26502/jcsct.5079218","DOIUrl":"10.26502/jcsct.5079218","url":null,"abstract":"<p><p>We recently reported a computational method (IDACombo) designed to predict the efficacy of cancer drug combinations using monotherapy response data and the assumptions of independent drug action. Given the strong agreement between IDACombo predictions and measured drug combination efficacy in vitro and in clinical trials, we believe IDACombo can be of immediate use to researchers who are working to develop novel drug combinations. While we previously released our method as an R package, we have now created an R Shiny application to allow researchers without programming experience to easily utilize this method. The app provides a graphical interface which enables users to easily generate efficacy predictions with IDACombo using provided data from several high-throughput cell line screens or using custom, user-provided data.</p>","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"7 4","pages":"253-258"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biophysical and Biological Mechanisms of Tumor Treating Fields in Glioblastoma. 胶质母细胞瘤肿瘤治疗场的生物物理和生物机制
Journal of cancer science and clinical therapeutics Pub Date : 2024-01-01 Epub Date: 2024-08-19 DOI: 10.26502/jcsct.5079249
Jeremy Pan, Tony Eskandar, Zubair Ahmed, Devendra K Agrawal
{"title":"Biophysical and Biological Mechanisms of Tumor Treating Fields in Glioblastoma.","authors":"Jeremy Pan, Tony Eskandar, Zubair Ahmed, Devendra K Agrawal","doi":"10.26502/jcsct.5079249","DOIUrl":"10.26502/jcsct.5079249","url":null,"abstract":"<p><p>Glioblastoma (GBM) is one of the most aggressive forms of brain cancer that presents with a median survival rate of 14-30 months and along with a discouraging five-year survival rate of 4-5%. Standard treatment of newly diagnosed GBM, also known as the Stupp protocol, includes a maximally safe surgical resection followed by radiation and chemotherapy. Despite these treatment regimens, recurrence is almost inevitable, emphasizing the need for new therapies to combat the aggressive nature of GBMs. Tumor Treating Fields (TTFs) are a relatively new application to the treatment of GBMs, and results have been promising with both progression-free survival and overall survival when TTFs have been used in combination with temozolomide. This article critically reviews the biophysical and biological mechanisms of TTFs, their clinical efficacy, and discusses the results in clinical trials, including EF-11 and EF-14. Both trials have demonstrated that TTFs can enhance progression free survival and overall survival without compromising quality of life or causing severe adverse effects. Despite the high cost associated with TTFs and the need for further analysis to determine the most effective ways to integrate TTFs into GBM treatments, TTFs represent a significant advancement in GBM therapy and offer hope for improved patient prognosis.</p>","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"8 3","pages":"265-270"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11448370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small-Cell Lung Cancer in a Cancer Center in Colombia 哥伦比亚癌症中心的小细胞肺癌研究
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079186
C. Carvajal, D. Ballen, Natallie Jurado,, Rafael Beltrán, M. Alarcón, Camilo Vallejo-Yepes, Marcela Núñez, R. Parra, Ricardo Brugés-Maya
{"title":"Small-Cell Lung Cancer in a Cancer Center in Colombia","authors":"C. Carvajal, D. Ballen, Natallie Jurado,, Rafael Beltrán, M. Alarcón, Camilo Vallejo-Yepes, Marcela Núñez, R. Parra, Ricardo Brugés-Maya","doi":"10.26502/jcsct.5079186","DOIUrl":"https://doi.org/10.26502/jcsct.5079186","url":null,"abstract":"","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69348405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different Coagulation Markers as Predictors of Severity in Cancer Patients with COVID-19 Infection 不同凝血指标作为COVID-19感染癌症患者严重程度的预测指标
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079194
F. Alfraih, Mostafa F. Mohammed Saleh, A. Abdrabou, A. Haroon, K. AlSaleh, T. Owaidah
{"title":"Different Coagulation Markers as Predictors of Severity in Cancer Patients with COVID-19 Infection","authors":"F. Alfraih, Mostafa F. Mohammed Saleh, A. Abdrabou, A. Haroon, K. AlSaleh, T. Owaidah","doi":"10.26502/jcsct.5079194","DOIUrl":"https://doi.org/10.26502/jcsct.5079194","url":null,"abstract":"","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69348526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spinal Intramedullary Ewing Sarcoma with Meningeal Carcinomatosis: A Complete Response to Chemotherapy and Neuroaxis Irradiation. Case Report and Review of Literature 脊髓尤文氏髓内肉瘤合并脑膜癌病:对化疗和神经轴照射的完全反应。病例报告及文献回顾
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079195
V. Albarrán, M. Villamayor, Ignacio Ruz, Jesús Chamorro, D. Rosero, J. Pozas, María San Román, P. A. Ballesteros, María Ángeles Vaz
{"title":"Spinal Intramedullary Ewing Sarcoma with Meningeal Carcinomatosis: A Complete Response to Chemotherapy and Neuroaxis Irradiation. Case Report and Review of Literature","authors":"V. Albarrán, M. Villamayor, Ignacio Ruz, Jesús Chamorro, D. Rosero, J. Pozas, María San Román, P. A. Ballesteros, María Ángeles Vaz","doi":"10.26502/jcsct.5079195","DOIUrl":"https://doi.org/10.26502/jcsct.5079195","url":null,"abstract":"","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69348532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liquiritigenin Enhances the Inhibitory Effects of the Cholesterol Biosynthesis Inhibitor RO 48-8071 on Cell Viability in Ovarian-Cancer Cells in Vitro 利尿素增强胆固醇生物合成抑制剂RO 48-8071对卵巢癌细胞活力的体外抑制作用
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079207
Yayun Liang, Salman M Hyder
{"title":"Liquiritigenin Enhances the Inhibitory Effects of the Cholesterol Biosynthesis Inhibitor RO 48-8071 on Cell Viability in Ovarian-Cancer Cells in Vitro","authors":"Yayun Liang, Salman M Hyder","doi":"10.26502/jcsct.5079207","DOIUrl":"https://doi.org/10.26502/jcsct.5079207","url":null,"abstract":"Almost 25,000 new cases of epithelial ovarian cancer (EOC) are reported each year in the United States. Cancers of the ovary have poor prognosis due to drug resistance and metastasis, and have the highest mortality rate of all the known gynecological malignancies. Despite concerted efforts to develop new strategies for preventing and treating ovarian cancer, novel and more effective non-toxic therapies for ovarian cancer are urgently needed. Recent observations show that RO 48-8071 ([4’-[6-(Allylmethylamino)hexyloxy]-4-bromo-2’-fluorobenzophenone fumarate] [RO], a small-molecule inhibitor of the key cholesterol biosynthesis enzyme 2, 3-oxidosqualene cyclase, inhibits breast and prostate cancer cells. RO also induces the tumor-suppressor protein estrogen receptor (ER) β in both breast- and prostate-cancer cells, and also inhibits growth of ovarian-cancer cells both in vitro and in vivo. Extending upon these earlier studies, here we found that RO also induces ERβ expression in OVCAR-3 ovarian-cancer cells. Further, we demonstrated that treatment of two ovarian-cancer cell lines (OVCAR-3 and SK-OV-3) with liquiritigenin (LQ), a naturally occurring compound that is an ERβ agonist, reduced cell viability in vitro. When we treated OVCAR-3 and SK-OV-3 cells with RO, LQ, or RO + LQ, we observed that RO + LQ combination treatment synergistically reduced cell viability. Further in vivo studies examining the effects of RO + LQ combination treatment on EOC are warranted, as a means of exploring a potential new therapeutic approach to combat ovarian cancers with minimal toxicity.","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135838181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung Hydatid Cysts in Children, Evaluation and Surgical Management 儿童肺包虫病的评估和外科治疗
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079189
Burkan Nasr, Anwar Al_junaeed, Ghaleb Al Sady, Ahmad Al Shehari, A. Amri, M. Issa, Abdulhakim Al Tamimi, Saeed Al Bahlooli, Mohammed Al_Sormi, Abdulfattah Altam, Yasser A Obadiel, M. Al-Shehari, Ali Hiddan.
{"title":"Lung Hydatid Cysts in Children, Evaluation and Surgical Management","authors":"Burkan Nasr, Anwar Al_junaeed, Ghaleb Al Sady, Ahmad Al Shehari, A. Amri, M. Issa, Abdulhakim Al Tamimi, Saeed Al Bahlooli, Mohammed Al_Sormi, Abdulfattah Altam, Yasser A Obadiel, M. Al-Shehari, Ali Hiddan.","doi":"10.26502/jcsct.5079189","DOIUrl":"https://doi.org/10.26502/jcsct.5079189","url":null,"abstract":"","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69348494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewing Stereotactic Body Radiation Therapy Boost after Neoadjuvant Chemoradiation as an Alternative to Brachytherapy Boost for Locally Advanced Cervical Cancer 新辅助放化疗后立体定向体放射强化治疗作为局部晚期宫颈癌近距离强化治疗的替代方案
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079196
{"title":"Reviewing Stereotactic Body Radiation Therapy Boost after Neoadjuvant Chemoradiation as an Alternative to Brachytherapy Boost for Locally Advanced Cervical Cancer","authors":"","doi":"10.26502/jcsct.5079196","DOIUrl":"https://doi.org/10.26502/jcsct.5079196","url":null,"abstract":"","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69348580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Experience of Palliative Care Patients Who Underwent Telemedicine in the State of Qatar during the COVID-19 Pandemic 卡塔尔国在2019冠状病毒病大流行期间接受远程医疗的姑息治疗患者的经历
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079201
A. Hassan, A. Allam, Saad Jobran Eziada, Hiba Elathir, Azar Saleeml, Sair Ibrahim, Zeinab Idris, Shaikhah Mohsen
{"title":"The Experience of Palliative Care Patients Who Underwent Telemedicine in the State of Qatar during the COVID-19 Pandemic","authors":"A. Hassan, A. Allam, Saad Jobran Eziada, Hiba Elathir, Azar Saleeml, Sair Ibrahim, Zeinab Idris, Shaikhah Mohsen","doi":"10.26502/jcsct.5079201","DOIUrl":"https://doi.org/10.26502/jcsct.5079201","url":null,"abstract":"","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69348640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the Quality of Life of Retinoblastoma Survivors: An Initial Exploration 研究视网膜母细胞瘤幸存者的生活质量:初步探索
Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI: 10.26502/jcsct.5079202
Krishnasri Padamandala, Santosh G. Honavar, Rolika Bansal, Surya Durga Prasad M, Padmaja Gadiraju, Geeta K Vemuganti
{"title":"Investigating the Quality of Life of Retinoblastoma Survivors: An Initial Exploration","authors":"Krishnasri Padamandala, Santosh G. Honavar, Rolika Bansal, Surya Durga Prasad M, Padmaja Gadiraju, Geeta K Vemuganti","doi":"10.26502/jcsct.5079202","DOIUrl":"https://doi.org/10.26502/jcsct.5079202","url":null,"abstract":"","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69348647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信